Nantes, France

Acb

Calculating rank
USPTO Granted Patents = 12



Forward Citations = 108

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Gerard Freneix (3 out of 4 patents)

silverMedal Jean-Paul Huet (2 out of 3 patents)

bronzeMedal Benoit Bourriau (1 out of 1 patent)

4.  Julien Clergeau (1 out of 1 patent)

5.  Philippe Blot (1 out of 22 patents)

6.  Michel Guglielmi (1 out of 2 patents)

7.  Henri Le Goff (1 out of 1 patent)

8.  Joel Bretagne (1 out of 2 patents)

9.  Philippe De Larminat (1 out of 1 patent)

10.  Thierry Legouis (1 out of 1 patent)

11.  Jacques Prevost (1 out of 1 patent)

12.  Jean-Marie Lebas (1 out of 2 patents)

13.  Bernard Ollivaud (1 out of 5 patents)

14.  Bernard Bioret (1 out of 2 patents)

15.  Joel Augereau (1 out of 1 patent)


12 patents:

Company Overview
Acb, headquartered in Nantes, France, specializes in the development and manufacturing of advanced solutions in the fields of biotechnology and medical devices. The company focuses on innovative technologies aimed at enhancing healthcare outcomes, with a strong emphasis on research and development. Acb is dedicated to addressing complex medical challenges through its expertise in diagnostics and therapeutic solutions, contributing to the advancement of patient care and treatment methodologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#10 in Nantes

#1,487 in France

#48,235 in the World

Nantes, FR
Nantes, France
Forward Citations = 108

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acb. Retrieved from https://idiyas.com/company/acb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…